Neumora’s main melancholy drug flunks first of 3 Segment 3 trials Endpoints NewsNeumora Therapeutics Inventory Crashes 83% After Melancholy Drug Flops Investor’s Trade DailyNeumora’s antidepressant stumbles in first Segment 3 trial readout STATNeumora Plunges After Melancholy Drug Fails in Ultimate-Level Find out about Yahoo FinanceNeumora’s main melancholy drug fails first of 3 pivotal research FirstWord Pharma
